Classification: GHRH Analogue
Acne: No
Water Retention: No
HBR: No
Hepatotoxicity: No
Aromatization: No
Manufacturer: Beligas
Warehouse: International Warehouse 3
Substance: GHRH Peptide
Introducing CJC-1295, a powerful synthetic analogue of growth hormone-releasing hormone (GHRH), meticulously crafted from 30 amino acids. This innovative peptide is designed to significantly boost the secretion of growth hormone and IGF-1 while preserving the body's natural pulsatile release of GH.
CJC-1295 is often used in synergy with Ipamorelin, enhancing specificity as a GHRH. This strategic pairing achieves remarkable growth hormone secretion without the unwanted appetite stimulation or elevated levels of cortisol, acetylcholine, prolactin, and aldosterone that can occur with other peptides. Users frequently report a high tolerance to this combination, making it an exceptional companion for Ipamorelin.
Target Gland: Pituitary
- Elevates growth hormone and IGF-1 levels without raising prolactin
- Enhances body weight and lean mass through superior protein synthesis
- Promotes muscle growth and development
- Increases bone density for improved structural integrity
- Supports immune system function
- Boosts cognitive abilities and enhances memory
- Stimulates collagen production for healthier skin
- Aids in fat reduction for a leaner physique
- Facilitates cellular repair and regeneration
Advantages of CJC-1295: This remarkable peptide also encourages deep, restorative slow-wave sleep, essential for maximizing muscle growth, optimizing memory retention, and promoting overall rejuvenation.
GHRH is naturally synthesized in the hypothalamus, stimulating the pituitary gland to release GH in a rhythmic manner. However, GHRH has a fleeting half-life of only a few minutes, resulting in rapid elimination from the bloodstream and brief effects.
Types of CJC-1295: The active segment of GHRH comprises the first 29 amino acids, marketed as the peptide Sermorelin. This was enhanced to extend its half-life to 30 minutes, giving rise to CJC-1295. Further modification introduced a Drug Affinity Complex (DAC) that binds to blood protein albumin, extending its half-life to approximately 8 days?referred to as CJC-1295 + DAC. CJC-1295 is also available in a non-DAC form, which mimics natural nightly GH spikes.
Due to the extended half-life from DAC, injections can be spaced out to once or twice weekly. However, this sustained presence in the bloodstream may lead to constant stimulation of GH release via the GHRH receptor, potentially dampening the natural physiological patterns and reducing the amplitude of GH pulses, which could affect GH-responsive tissues.
For optimal results while using a long-acting CJC molecule, consider taking "hormone holidays" every three to six months, lasting three months each, to allow your pituitary gland to recuperate. During these breaks, Sermorelin is recommended as a substitute for CJC-1295 + DAC.
Safety Considerations: These 'hormone holidays' may also mitigate the risk of developing GH resistance, which could be due to antibodies neutralizing GH or a decrease in GH receptors on tissues (down-regulation). While these concerns remain theoretical due to a lack of extensive long-term studies, they warrant consideration.
Possible side effects of CJC-1295 may include injection site reactions (such as irritation, redness, swelling, pain, and itching), headaches, diarrhea, vasodilation (including flushing, warmth, and temporary low blood pressure), nausea, and abdominal discomfort.